Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in Western women

Circulation

Volumn 111, Issue 4, 2005, Pages 465-471

  Van Der Schouw, Yvonne T ^a   Kreijkamp Kaspers, Sanne ^a   Peeters, Petra H M ^a   Keinan Boker, Lital ^a   Rimm, Eric B ^b   Grobbee, Diederick E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cerebrovascular disorders; Coronary disease; Epidemiology; Nutrition; Women

Indexed keywords

ISOFLAVONE DERIVATIVE; LIGNAN; PHYTOESTROGEN;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DIETARY INTAKE; ESTROGEN THERAPY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MENOPAUSE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK REDUCTION; WESTERN EUROPE;

AGED; ALCOHOL DRINKING; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; CORONARY DISEASE; DIETARY FIBER; ENERGY INTAKE; FEMALE; FOLLOW-UP STUDIES; FOOD HABITS; FRUIT; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISOFLAVONES; LIGNANS; MENOPAUSE; MIDDLE AGED; NETHERLANDS; NUTRITION SURVEYS; PHYTOESTROGENS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK; SMOKING; VEGETABLES;

EID: 13444292085     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000153814.87631.B0     Document Type: Article

References (31)

1. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997;138:863-870.
2. Zava DT, Dollbaum CM, Blen M. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc Soc Exp Biol Med. 1998;217:369-378.
3. Baker VA, Hepburn PA, Kennedy SJ, Jones PA, Lea LJ, Sumpter JP, Ashby J. Safety evaluation of phytosterol esters, I: assessment of oestrogenicity using a combination of in vivo and in vitro assays. Food Chem Toxicol. 1999;37:13-22.
4. Saarinen NM, Warri A, Makela SI, Eckerman C, Reunanen M, Ahotupa M, Salmi SM, Franke AA, Kangas L, Santti R. Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr Cancer. 2000;36:207-216.
5. de Kleijn MJ, van der Schouw YT, Wilson PW, Adlercreutz H, Mazur W, Grobbee DE, Jacques PF. Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham Study. J Nutr. 2001;131:1826-1832.
6. Anderson JW, Johnstone BM, Cook Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids [see comments]. N Engl J Med. 1995;333:276-282.
7. Kreijkamp-Kaspers S, Kok L, Grobbee DE, De Haan EH, Aleman A, Lampe JW, van der Schouw YT. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA. 2004;292:65-74.
8. Nestel PJ, Yamashita T, Sasahara T, Pomeroy S, Dart A, Komesasoft P, Owen A, Abbey M. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol. 1997;17:3392-3398.
9. Walker HA, Dean TS, Sanders TA, Jackson G, Ritter JM, Chowienczyk PJ. The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17ss-estradiol. Circulation. 2001;103:258-262.
10. Vanharanta M, Voutilainen S, Lakka TA, van der Lee M, Adlercreutz H, Salonen JT. Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet. 1999;354:2112-2115.
11. Vanharanta M, Voutilainen S, Rissanen TH, Adlercreutz H, Salonen JT. Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med. 2003;163:1099-1104.
12. Riboli E. Nutrition and cancer: background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann Oncol. 1992;3:783-791.
13. Boker LK, van Noord PA, van der Schouw YT, Root NV, de Mesquita HB, Riboli E, Grobbee DE, Peeters PH. Prospect-EPIC Utrecht: study design and characteristics of the cohort population. European Prospective Investigation into Cancer and Nutrition. Eur J Epidemiol. 2001;17:1047-1053.
14. Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, Van Staveren WA. A physical activity questionnaire for the elderly. Med Sci Sports Exerc JID - 8005433. 1991;23:974-979.
15. Little RA, Rubin DB. Statistical Analysis With Missing Data. New York, NY: Wiley; 1987.
16. Ocke MC, Bueno-de-Mesquita HB, Pols MA, Smit HA, Van Staveren WA, Kromhout D. The Dutch EPIC food frequency questionnaire, II: relative validity and reproducibility for nutrients. Int J Epidemiol. 1997;26(suppl I):S49-S58.
17. Ocke MC, Bueno-de-Mesquita HB, Goddijn HE, Jansen A, Pols MA, Van Staveren WA, Kromhout D. The Dutch EPIC food frequency questionnaire, I: description of the questionnaire, and relative validity and reproducibility for food groups. Int J Epidemiol. 1997;26(suppl 1):S37-S48.
18. Willett W, Stampfer M. Implications of total energy intake for epidemiologic analyses. In: Willett W, ed. Nutritional Epidemiology. New York, NY: Oxford University Press; 1998:273-301.
19. Boker LK, van der Schouw YT, de Kleijn MJ, Jacques PF, Grobbee DE, Peeters PH. Intake of dietary phytoestrogens by Dutch women. J Nutr. 2002;132:1319-1328.
20. Herings RM, Bakker A, Stricker BH, Nap G. Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health. 1992;46:136-140.
21. Cox DR. Regression models and life tables. J R Stat Soc [B]. 1972;34:187-220.
22. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer [see comments]. Lancet. 1997;350:990-994.
23. Strom SS, Yamamura Y, Duphorrte CM, Spitz MR, Babaian RJ, Pillow PC, Hursting SD. Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr Cancer. 1999;33:20-25.
24. Horn-Ross PL, Hoggatt KJ, Lee MM. Phytoestrogens and thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Cancer Epidemiol Biomarkers Prev. 2002;11:43-49.
25. Horn-Ross PL, John EM, Lee M, Stewart SL, Koo J, Sakoda LC, Shiau AC, Goldstein J, Davis P, Perez-Stable EJ. Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J Epidemiol. 2001;154:434-441.
26. Horn-Ross PL, Barnes S, Lee M, Coward L, Mandel JE, Koo J, John EM, Smith M. Assessing phytoestrogen exposure in epidemiologic studies: development of a database (United States). Cancer Causes Control. 2000;11:289-298.
27. Messina M. Isoflavone intakes by Japanese were overestimated [letter; comment]. Am J Clin Nutr. 1995;62:645.
28. de Kleijn MJ, van der Schouw YT, Wilson PW, Grobbee DE, Jacques PF. Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S. women: the Framingham study. J Nutr. 2002;132:276-282.
29. van der Schouw YT, Pijpe A, Lebrun CE, Bots ML, Peeters PH, Van Staveren WA, Lamberts SW, Grobbee DE. Higher usual dietary intake of phytoestrogens is associated with lower aortic stiffness in postmenopausal women. Arterioscler Thromb Vasc Biol. 2002;22:1316-1322.
30. Jenkins DJ, Kendall CW, Vidgen E, Agarwal S, Rao AV, Rosenberg RS, Diamandis EP, Novokmet R, Mehling CC, Perera T, Griffin LC, Cunnane SC. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial. Am J Clin Nutr. 1999;69:395-402.
31. Lucas EA, Wild RD, Hammond LJ, Khalil DA, Juma S, Daggy BP, Stoecker BJ, Arjmandi BH. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab. 2002;87:1527-1532.